Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.34 AUD | -6.85% |
|
+13.33% | +94.29% |
May. 29 | Study Finds Cleo Diagnostics ' Blood Test Outperforms Clinical Benchmarks | MT |
Apr. 11 | Cleo Diagnostics Taps Lindus Health to Manage US Ovarian Cancer Clinical Trials | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+94.29% | 31.17M | |
-10.64% | 11.61B | |
-11.02% | 7.65B | |
+30.85% | 5.62B | |
-16.28% | 3.85B | |
+8.39% | 2.62B | |
-64.67% | 2.37B | |
-10.53% | 2.24B | |
+24.87% | 2.16B | |
-12.06% | 1.76B |
- Stock Market
- Equities
- COV Stock
- News Cleo Diagnostics Ltd
- Cleo Diagnostics Confirms Efficacy of Ovarian Cancer Test from Validation Study; Shares Surge 21%